Cargando…
Ipsen 5i is a Novel Potent Pharmacoperone for Intracellularly Retained Melanocortin-4 Receptor Mutants
Inactivating mutations of the melanocortin-4 receptor (MC4R) cause early-onset severe obesity in humans. Comprehensive functional studies show that most of the inactivating mutants of the MC4R are retained intracellularly. In the present study, we investigated whether a small molecule inverse agonis...
Autores principales: | Tao, Ya-Xiong, Huang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120685/ https://www.ncbi.nlm.nih.gov/pubmed/25136332 http://dx.doi.org/10.3389/fendo.2014.00131 |
Ejemplares similares
-
A Small Molecule Agonist THIQ as a Novel Pharmacoperone for Intracellularly Retained Melanocortin-4 Receptor Mutants
por: Huang, Hui, et al.
Publicado: (2014) -
Pharmacoperone Identification for Therapeutic Rescue of Misfolded Mutant Proteins
por: Conn, P. Michael, et al.
Publicado: (2011) -
Regulation of Melanocortin-4 Receptor Pharmacology by Two Isoforms of Melanocortin Receptor Accessory Protein 2 in Topmouth Culter (Culter alburnus)
por: Tao, Min, et al.
Publicado: (2020) -
Melanocortin Regulation of Inflammation
por: Wang, Wei, et al.
Publicado: (2019) -
OR03-01 Functional Rescue Of Trafficking-Defective Mutant Follicle-Stimulating Hormone Receptors (FSHR) Leading To Premature Ovarian Failure With The Pharmacoperone CAN1405
por: Ulloa-Aguirre, Alfredo, et al.
Publicado: (2023)